Trade

Dr Reddy's Laboratories share price

Moderate risk
  • 20%Low risk
  • 20%Moderate risk
  • 20%Balanced risk
  • 20%High risk
  • 20%Extreme risk
  • ₹1,205.30(0.02%)
    November 7, 2025 07:50:00 AM IST
    • NSE
    • BSE
  • Vol : 1.09M (NSE + BSE)
    Last 20 day avg : 2.25 M

Dr Reddy's Laboratories is trading 0.02% upper at Rs 1,205.30 as compared to its last closing price. Dr Reddy's Laboratories has been trading in the price range of 1,211.70 & 1,198.80. Dr Reddy's Laboratories has given -13.19% in this year & 0.27% in the last 5 days. Dr Reddy's Laboratories has TTM P/E ratio 17.66 as compared to the sector P/E of 29.66.There are 38 analysts who have initiated coverage on Dr Reddy's Laboratories. There are 6 analysts who have given it a strong buy rating & 7 analysts have given it a buy rating. 8 analysts have given the stock a sell rating.The company posted a net profit of 1,347.10 Crores in its last quarter.Listed peers of Dr Reddy's Laboratories include Cipla (0.29%), Torrent Pharmaceuticals (0.58%), Dr Reddys Laboratories (0.02%).The Mutual Fund holding in Dr Reddy's Laboratories was at 13.31% in 30 Sep 2025. The MF holding has decreased from the last quarter. The FII holding in Dr Reddy's Laboratories was at 24.69% in 30 Sep 2025. The FII holding has decreased from the last quarter.

  • Overview
  • Financials
  • Forecast
  • Technical Analysis
  • Peers
  • Shareholding
  • About the company
  • FAQ

Overview

  • 1 D
  • 5 D
  • 1 M
  • 3 M
  • 6 M
  • 1 Y
  • 5 Y
  • MAX
Explore on
Key Metrics

Updated on Nov 10, 2025, 03:29 AM UTC

  • Beta
    Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
    0.47
    Low volatility
  • Debt To Equity
    The debt-to-equity ratio, indicating a company's financial leverage.
    0.14
    Higher than industry
  • Dividend Yield
    Annual dividends as a percentage of the stock price.
    0.66
    Lower than industry
  • P/B
    The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
    2.99
    Lower than historical values
  • P/E
    Price-to-earnings ratio based on trailing 12-month earnings
    17.41
    Lower than historical values
  • PEG Ratio
    The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
    0.47
    Indicates undervaluation
Price range
Day Range
Lowest
1,198.80
Highest
1,211.70
52 week range
Lowest
1,025.90
Highest
1,404.60
Dr Reddy's Laboratories Financials
Financials
Financials include key reports like the Profit & Loss Statement (P&L), Balance Sheet, and Cash Flow Statement, providing insights into a company's performance, financial health, and liquidity
View all
  • Income
  • Balance Sheet
  • Cash Flow
Loading...
Units in the chart are in crores
Insights
  • Financial
  • Valuation
    • financial-insightsCompany is profitable
    • financial-insightsThe company's revenue grew in September quarter by 9.83% from Rs 8828.30 crore to Rs 8038.20 crore, year-on-year
    • financial-insightsThe company has grown its September quarter profit by 7.28% from Rs 1255.70 crore to Rs 1347.10 crore, year-on-year
    • financial-insightsThe debt to equity of the company is higher than the industry median
    • financial-insightsCompany can comfortably pay off its interest obligations with its earnings
Dr Reddy's Laboratories Technical Analysis
Pivot Level - classic
Info
Key price levels (support and resistance) calculated using the previous day's high, low, and close, aiding in technical analysis and trading decisions
  • R1
  • 1,210.60
  • R2
  • 1,224.75
  • R3
  • 1,236.05
Pivot1,199.30
  • S1
  • 1,185.15
  • S2
  • 1,173.85
  • S3
  • 1,159.70
Short Term
Info
Considers price movement over the last 1-2 weeks
Not Available
Long Term
Info
Considers price movement over the last 6 months
Not Available
  • Very Bearish
  • Bearish
  • Neutral
  • Very Bullish
  • Bullish
Trends unavailable at the moment.
Dr Reddy's Laboratories Peers
Return Comparison
Peers Comparison
Names
Technical ratingPrice%ChangeMarket CapP/EP/BDividend YieldDebt to Equity
Cipla
Moderately Bearish
1,504.450.291,21,524.3123.143.910.860.81
Torrent Pharmaceuticals
Bullish
3,579.500.581,21,293.5958.5214.870.9617.63
Dr Reddys Laboratories
Bearish
1,205.300.021,00,591.2919.003.20.622.34
Zydus Lifesciences
Bearish
943.800.8194,968.3621.434.21.100.13
Lupin
Moderately Bullish
1,971.500.7690,080.3627.275.190.4111.80
Dr Reddy's Laboratories Shareholding
View All
Shareholding Pattern
Breakdown of a company's ownership structure, showing stakes held by Promoters, Mutual Funds, FII(s) & Others.
    No Data
    Shareholding pattern for Dr Reddy's Laboratories is currently unavailable
    Please check back later.
    Shareholding Insights
    • InsightsPromoter(s) does not have a high stake in the company
    • InsightsFIIs are invested in this company
    • InsightsFIIs holding has decreased by 0.64 percentage points from previous quarter
    • InsightsMutual Funds holding has decreased by 0.30 percentage points from previous quarter
    Mutual Fund Ownership
    View all
    ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Growth
    NA
    • Amount Invested (Cr.) 531.78
    • % of AUM 9.66
    PGIM India Healthcare Fund Regular Growth
    NA
    • Amount Invested (Cr.) 6.87
    • % of AUM 6.31
    Bandhan BSE Healthcare Index Fund Regular Growth
    NA
    • Amount Invested (Cr.) 1.09
    • % of AUM 5.99
    Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Regular Growth
    NA
    • Amount Invested (Cr.) 8.73
    • % of AUM 5.58
    Nippon India Pharma Fund - Growth
    NA
    • Amount Invested (Cr.) 458.22
    • % of AUM 5.49
    Dr Reddy's Laboratories Corporate Actions
    View all
    • Board Meetings
    • AGM
    • Dividends
    • Bonus
    • Split
    • Rights
    Meeting DatePurpose
    2025-10-24Quarterly Results
    2025-05-09Audited Results, Dividend & Others
    2025-01-23Quarterly Results
    2024-11-05Quarterly Results
    2024-07-27Quarterly Results & Stock Split
    About the company Dr Reddy's Laboratories
    • IndustryBiotechnology & Drugs
    • ISININE089A01031
    • BSE Code500124
    • NSE CodeDRREDDY
    Dr. Reddy’s Laboratories Limited is an India-based pharmaceutical company. Its products and services are spread across its core businesses of active pharmaceutical ingredients (APIs), generics, branded generics, biosimilars and over-the-counter (OTC) pharmaceutical products. It works in the areas of gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. Its segments consist of Global Generics; Pharmaceutical Services and Active Ingredients (PSAI), and Others. The Global Generics segment consists of the Company's business of manufacturing and marketing prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name (branded formulations) or as generic finished dosages with therapeutic equivalence to branded formulations (generics). The Pharmaceutical Services and Active Ingredients segment consists of the Company's business of manufacturing and marketing APIs and intermediates.
    • Management Info
    • Kallam ReddyChairman of the Board
    • Gunupati PrasadCo-Chairman of the Board, Managing Director
    • Erez IsraeliChief Executive Officer
    • M. V. NarasimhamChief Financial Officer
    • Milan KalawadiaChief Executive Officer, North America
    • M. RamanaChief Executive Officer, Branded Markets (India and Emerging Countries)
    • Archana BhaskarChief Human Resources Officer
    • Phani Mitra B.Chief Information Officer
    • Patrick AghanianHead of Generics, Europe, and Head of Consumer Health
    • Sushrut KulkarniGlobal Head of Integrated Product Development Organisation
    Dr Reddy's Laboratories Share Price FAQs

    Dr Reddy's Laboratories is trading at 1205.30 as on Fri Nov 07 2025 02:20:00. This is 0.02% upper as compared to its previous closing price of 1205.30.

    The market capitalization of Dr Reddy's Laboratories is 100591.29 Cr as on Fri Nov 07 2025 02:20:00.

    The average broker rating on Dr Reddy's Laboratories is Hold. The breakup of analyst rating is given below -

    • 6 analysts have given a strong buy rating
    • 7 analysts have given a buy rating
    • 12 analysts have given a hold rating
    • 8 analysts have given a sell rating
    • 5 analysts have given a strong sell rating

    The 52 wk high for Dr Reddy's Laboratories is 1404.60 whereas the 52 wk low is 1025.90

    Dr Reddy's Laboratories can be analyzed on the following key metrics -

    • TTM P/E: 17.66
    • Sector P/E: 29.66
    • Dividend Yield: 0.66%
    • D/E ratio: 0.16

    Dr Reddy's Laboratories reported a net profit of 5655.10 Cr in 2025.

    The Mutual Fund Shareholding was 13.31% at the end of 30 Sep 2025.

    Quick Links
    EQUITY QUICK LINKS
    Dr Reddy's Laboratories QUICK LINKS
    FROM MARKETS
    RELATED LINKS
    Quarterly Results
    Business News/Market/Market Stats/   Dr Reddy's Laboratories share price

    Wait for it…

    Log in to our website to save your bookmarks. It'll just take a moment.